Friday
SESSION XXVIII: MORE ON THORACIC AORTIC ANEURYSMS (TAAS) AND AAAS AND THEIR TREATMENT AND PREVENTION (5-MINUTE TALKS)
SESSION XXVIII SCHEDULE
1:00 PM - 1:05 PM Improved Grafts For TEVAR: The VALIANT And CAPTIVA Systems: Early Results
  Presenters(s):Ronald M. Fairman, MD  
1:06 PM - 1:11 PM New Findings From The INSTEAD Trial: Remodeling With And Without Endograft Treatment: What Is The Significance Of The Differing Results?
  Presenters(s):Christoph A. Nienaber, MD, PhD  
1:12 PM - 1:17 PM CT Follow-up After EVAR Is Bad For The Kidneys
  Presenters(s):Jan S. Brunkwall, MD, PhD  
1:18 PM - 1:23 PM Preoperative Relative AAA Thrombus Burden Predicts Endoleak And Sac Enlargement After EVAR
  Presenters(s):Thomas S. Maldonado, MD  
1:24 PM - 1:29 PM Bioenhanced Devices With Local Drug Delivery Have A Role In AAA Treatment
  Presenters(s):Ronald L. Dalman, MD  
1:30 PM - 1:35 PM New Technology For Extravascular Or Intravascular Stabilization Of AAAs: The VATRIX System To Influence The AAA Wall
  Presenters(s):Christopher J. Kwolek, MD  
1:36 PM - 1:41 PM Debate 17: We Must Have Level I Evidence That EVAR Is Better Than Open Repair For Ruptured AAAs
  Presenters(s):Nicholas J.W. Cheshire, MD  
1:42 PM - 1:47 PM Debate 17: EVAR For Ruptured AAAs Is Better: Open Treatment If The Patient Has Favorable Anatomy Is Akin To Murder
  Presenters(s):Sherif Sultan, MD, FRCS, EBQS-VASC  
1:48 PM - 1:53 PM How Best To Treat Patients With An AAA And Iliac Occlusive Disease: Tips And Tricks
  Presenters(s):Andrew Holden, MBChB  
1:54 PM - 1:59 PM Duplex Ultrasonography Done Early After EVAR Can Predict Which Type II Endoleaks Are Going To Persist And Lead To AAA Sac Enlargement
  Presenters(s):Keith D. Calligaro, MD  
2:00 PM - 2:05 PM How Often Does Embolization Of Type II Endoleaks Prevent Sac Expansion: What Can Be Done When It Fails?
  Presenters(s):Timur P. Sarac, MD  
2:06 PM - 2:12 PM Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 28.1 - 1-Year Trial Results With The VALIANT Stent-Graft For Treatment Of Complicated Type B Aortic Dissections
  Presenters(s):Matt M. Thompson, MD  
END OF SESSION XXVIII
previous next